Breaking News
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
February 21, 2019 - Overweight, obesity in adolescence associated with increased risk of renal cancer later in life
February 21, 2019 - BGU develops new AI platform for monitoring and predicting ALS progression
February 21, 2019 - Researchers discover a new promising target to improve HIV vaccines
February 21, 2019 - Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
February 21, 2019 - Gaming system helps with autism diagnosis
February 21, 2019 - Heart Disease: Six Things Women Should Know
February 21, 2019 - More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
February 21, 2019 - Researchers explore case studies focused on industries that kill more people than employed
February 21, 2019 - Only half of GP practice buildings are fit for purpose
February 21, 2019 - Intense exercise, fasting and hormones can enhance waste-protein removal, study shows
February 21, 2019 - Scientists can monitor brain activity to predict epileptic seizures few minutes in advance
February 21, 2019 - Study quantifies hepatic and intestinal mRNA expression of Ugt isoforms in rats
February 21, 2019 - ‘Apple-Shaped’ Body? ‘Pear-Shaped’? Your Genes May Tell
February 21, 2019 - Can we repair the brain? The promise of stem cell technologies for treating Parkinson’s disease
February 21, 2019 - Trump Plan To Beat HIV Hits Rough Road In Rural America
February 21, 2019 - PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms
February 21, 2019 - Trump plan to beat HIV hits rough road in rural America
February 21, 2019 - Eating blueberries every day could help decrease blood pressure
February 21, 2019 - ‘No Second Chances’ report calls for new measures to combat cardiovascular disease in Australia
February 21, 2019 - Mayo clinic researchers discuss local case studies of leprosy
February 21, 2019 - Scientists demonstrate key role of salt in allergic immune reactions
February 21, 2019 - Experts propose revising the criteria for diagnosis of Parkinson’s disease
February 21, 2019 - The med student and the machine
February 21, 2019 - Hey, Hey! Ho, Ho! Is Striking For School Nurses The Way To Go?
February 21, 2019 - Latest research encourages children to move out and learn through physical activity
February 21, 2019 - Proper oral hygiene and regular visits to dentist can promote heart health
Neuroengineering in three-dimensional brain-like microenvironments

Neuroengineering in three-dimensional brain-like microenvironments

image_pdfDownload PDFimage_print
An illustrated model compares a 2D stiff environment (left) with a 3D soft brain-like microenvironment (right) to reprogram neurons from somatic cells in the lab. Biophysical and biomechanical cues from the 3D microenvironment can boost direct neuronal reprogramming. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8

The human brain is organized of highly complex and expansive cellular and neuronal networks, but the existing scientific understanding of the developing brain is proportionately limited. Neuroengineering is an evolving field that employs advanced technology to manipulate neurons. The discipline can develop disease models of the central and peripheral nervous system to grasp neurological disorders, and produce next-generation biomaterials for neural tissue engineering. The ability to directly reprogram and convert mature cells such as fibroblasts (somatic cells) into neurons has also presented promising therapeutic potential. Technology for neuroengineering aims to design and create a broad range of applications to regulate neurons.

Neuroscientists have recently shown that brain extracellular matrix (BEM) decellularized from human brain tissue can simplify the conversion of primary mouse embryonic fibroblasts directly into induced neuronal (iN) cells in the lab. The iN cells generated on BEM substrates were transplanted in the brain of an animal model of ischemic stroke, leading to significant improvements in locomotive behaviors. The study also showed that combining 3-D BEM hydrogels with microfluidics could recreate brain-like microenvironments with higher efficacy to boost direct reprogramming and neuronal conversion, to promote functional recovery of animals after cell transplantation. The research is published in Nature Biomedical Engineering.

During neuronal reprogramming, the engineered 3-D system is believed to stimulate Yes-associated protein (YAP) and histone modifications for mechanosensitive signaling. The 3-D BEM hydrogel may also provide microenvironmental memory to retain functional phenotypes of the induced neuronal (iN) cells acquired during the conversion process. In the study, Seung-Woo Cho and co-workers first extracted brain extracellular matrix (ECM) from donor-human brain tissue to create a solubilized mixture of brain-specific native components. The solution was then used to develop and test 2-D surface coatings or 3-D systems to culture fibroblasts undergoing direct neuronal programming in the lab.

The illustrated neuroengineering procedure: decellularization of native brain tissue to produce solubilized brain extracellular matrix (BEM) to create 2D and 3D BEM platforms to reprogram fibroblasts into functional neurons. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

Direct conversion of mature somatic cells into different cell types, as seen in this instance with fibroblasts to neurons, in the presence of tissue-specific transcription factors, is known as trans-differentiation. In contrast to typical viral delivery systems, plasmids were used as the biomedical delivery vehicle of choice to transfect neuron tissue-specific elements, including BAM factors, via electroporation into the fibroblasts for induced neuronal transdifferentiation. The study showed that BEM significantly accelerated direct neuronal reprogramming, since induced neurons showed electrophysiological functions and mature neuronal marker expression as early as 14 days under laboratory conditions of cell differentiation. Immunocytochemistry and genetic analyses showed improved growth and differentiation with BEM compared to conventional biomaterials such as laminin and fibronectin, often used to fabricate 2-D extracellular matrix (ECM) coatings.

Neuroengineering in Three-dimensional Brain-like Microenvironments
Immunocytochemistry results: by day 14, the population of iN cells that stained positive for both neuron specific class III tubulin (Tuj1) and highly mature neuronal phenotype markers synapsin I (SYN1) or post synaptic density protein 95 (PSD-95) was greater in the 0.01 mg/ml BEM group than in the laminin group (LN) or in the laminin-fibronectin (LN+FN) group. DAPI (blue) stains nuclei. The region within the white box is magnified and displayed in the yellow square. BEM enhanced the direct neuronal conversion of primary fibroblasts to generate iN cells at an optimal concentration of 0.01 mg/ml. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

After completing extensive gene expression profiles and electrophysiological tests to characterize iN cells in the lab, scientists transplanted BEM-based iN cells into an adult mouse model of ischemic stroke exhibiting hypoxic brain injury to observe their therapeutic potential. In addition to neurogenesis, the paracrine effects of iN cell transplantation restored motor coordination and locomotor movement in the mice, demonstrating therapeutic efficacy.

Interestingly, cells cultured on 3-D BEM hydrogels showed higher expression levels of neuronal markers compared to 2-D BEM, indicating that biomimetic brain-like microenvironments can provide optimal biochemical and biophysical cues to guide cell reprogramming. Researchers then ingeniously combined 3-D BEM hydrogels with a microfluidic system (3-D µBEM), to amplify the autocrine and paracrine signaling of iN cells in a confined microenvironment and boost neuronal transdifferentiation.

Immunostaining analysis of iN cell cultures in multiple 3D materials, comparing conventional collagen (Col) and Matrigel (Mat) with 3D BEM, the expression of neuronal markers (Tuj1 and microtubule associated protein-2 MAP2) was significantly increased in the 3D BEM group. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

When such iN cells reprogrammed within brain-like 3-D µBEM environments were collected and transplanted in an ischemic stroke mouse model, functional recovery and therapeutic efficacy were noted. To illuminate the underlying the molecular mechanisms, scientists proposed that biophysical cues in a 3-D brain-like microenvironment may specifically induce YAP (Yes-associated protein) localization to the cellular cytoplasm to promote neuronal transdifferentiation. In contrast, stiff 2-D environments induced nuclear YAP localization, repressing neurogenesis-related gene expression, as observed in the study.

Understanding the molecular mechanisms of direct neural reprogramming for implantation in an animal model of ischemic stroke: a) immunostaining YAP (green) to quantify YAP localization in 2D and 3D conditions, b) tracking Dil-labelled (red, long-term tracer of neurons) iN cells generated from 3D µBEM at day 7 after cell injection in the striatum and cortex within the ischemic brain of an animal model. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

The study sheds light on the molecular mechanisms underlying direct neurogenesis, together with strategies to design and develop optimized biomaterials for improved neural reprogramming, reproducible in the lab. Brain-like 3-D biomimetic microenvironments can provide biochemical, biophysical, mechanical and epigenetic stimuli to efficiently reprogram neurons. Key insights from the study can be translated in the future to design and engineer a synthetic brain-like matrix to generate safe iN cells for regenerative and medical applications in neuroengineering.


Explore further:
Direct conversion of non-neuronal cells into nerve cells

More information:
Three-dimensional brain-like microenvironments facilitate the direct reprogramming of fibroblasts into therapeutic neurons www.nature.com/articles/s41551-018-0260-8 Jin et al, 11 July 2018, Nature Biomedical Engineering.

Liver extracellular matrix providing dual functions of two-dimensional substrate coating and three-dimensional injectable hydrogel platform for liver tissue engineering pubs.acs.org/doi/10.1021/bm4015039 Lee et al, 2014, Biomacromolecules.

Heart repair by reprogramming non-myocytes with cardiac transcription factors www.ncbi.nlm.nih.gov/pmc/articles/PMC3367390/ Song et al, 2012, Nature.

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes www.ncbi.nlm.nih.gov/pmc/articles/PMC3369107/ Qian et al, 2012, Nature.

High-efficiency cellular reprogramming with microfluidics www.nature.com/articles/nmeth.3832 Luni et al, 2016, Nature Methods.

Biophysical regulation of epigenetic state and cell reprogramming www.nature.com/articles/nmat3777 Downing et al, 2013, Nature Materials.

3-D niche microarrays for systems-level analyses of cell fate www.nature.com/articles/ncomms5324 Ranga et al, 2014, Nature Communications.

Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification www.pnas.org/content/111/38/13805 Musah et al, 2014, Proceedings of the National Academy of Sciences.

Tagged with:

About author

Related Articles